Lurie Cancer Center received a renewed Specialized Program of Research Excellence (SPORE) grant from the National Cancer Institute in 2023 to advance translational research and improve outcomes for patients with brain cancer.
The Lurie Cancer Center Brain Tumor SPORE is led by Maciej Lesniak, MD, chair and the Michael J. Marchese Professor of Neurosurgery, with projects led by members of the Department of Neurosurgery and the Ken and Ruth Davee Department of Neurology. The SPORE focuses on improving treatment strategies for highly malignant brain tumors, with an emphasis on developing novel approaches for patients with glioblastoma, the most common and aggressive type of primary brain tumor. The SPORE is one of just six brain tumor programs nationwide to receive the designation and recognizes Northwestern as a premier institution for innovative, translational research. The NCI’s SPORE grants fund interdisciplinary, collaborative research projects in specific cancer types and are intended to rapidly move research discoveries from the laboratory into the clinic. |
Â
February 2024 Â
November 2023 |
About Us Terms of Use Privacy Policy How to Vote for U.S. News & World Report Best Hospitals
© 2024 Northwestern Medicine® and Northwestern Memorial HealthCare. Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University |
Connect with us
breakthroughsforphysicians@nm.org International physicians, contact international@nm.org |